
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC285e-2]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
              SUBCHAPTER III--NATIONAL RESEARCH INSTITUTES
 
   Part C--Specific Provisions Respecting National Research Institutes
 
                 subpart 5--national institute on aging
 
Sec. 285e-2. Alzheimer's Disease centers


(a) Cooperative agreements and grants for establishing and supporting

    (1) The Director of the Institute may enter into cooperative 
agreements with and make grants to public or private nonprofit entities 
(including university medical centers) to pay all or part of the cost of 
planning, establishing, or strengthening, and providing basic operating 
support (including staffing) for centers for basic and clinical research 
(including multidisciplinary research) into, training in, and 
demonstration of advanced diagnostic, prevention, and treatment methods 
for Alzheimer's disease.
    (2) A cooperative agreement or grant under paragraph (1) shall be 
entered into in accordance with policies established by the Director of 
NIH and after consultation with the Institute's advisory council.

(b) Use of Federal payments under cooperative agreement or grant

    (1) Federal payments made under a cooperative agreement or grant 
under subsection (a) of this section may, with respect to Alzheimer's 
disease, be used for--
        (A) diagnostic examinations, patient assessments, patient care 
    costs, and other costs necessary for conducting research;
        (B) training, including training for allied health 
    professionals;
        (C) diagnostic and treatment clinics designed to meet the 
    special needs of minority and rural populations and other 
    underserved populations;
        (D) activities to educate the public; and
        (E) the dissemination of information.

    (2) For purposes of paragraph (1), the term ``training'' does not 
include research training for which National Research Service Awards may 
be provided under section 288 of this title.

(c) Support period; additional periods

    Support of a center under subsection (a) of this section may be for 
a period of not to exceed five years. Such period may be extended by the 
Director for additional periods of not more than five years each if the 
operations of such center have been reviewed by an appropriate technical 
and scientific peer review group established by the Director and if such 
group has recommended to the Director that such period should be 
extended.

(July 1, 1944, ch. 373, title IV, Sec. 445, as added Pub. L. 99-158, 
Sec. 2, Nov. 20, 1985, 99 Stat. 855; amended Pub. L. 101-557, title II, 
Sec. 201, Nov. 15, 1990, 104 Stat. 2767.)


                               Amendments

    1990--Subsec. (a)(1). Pub. L. 101-557, Sec. 201(1), inserted 
``(including university medical centers)'' after ``nonprofit entities'', 
``(including staffing)'' after ``operating support'', and ``(including 
multidisciplinary research)'' after ``clinical research'' and 
substituted ``Alzheimer's disease'' for ``Alzheimer's Disease''.
    Subsec. (b). Pub. L. 101-557, Sec. 201(2), amended subsec. (b) 
generally. Prior to amendment, subsec. (b) read as follows: ``Federal 
payments made under a cooperative agreement or grant under subsection 
(a) of this section may be used for--
        ``(1) construction (notwithstanding any limitation under section 
    289e of this title);
        ``(2) staffing and other basic operating costs, including such 
    patient care costs as are required for research;
        ``(3) training, including training for allied health 
    professionals; and
        ``(4) demonstration purposes.
As used in this subsection, the term `construction' does not include the 
acquisition of land, and the term `training' does not include research 
training for which National Research Service Awards may be provided 
under section 288 of this title.''


                      Alzheimer's Disease Research

    Pub. L. 100-175, title III, Nov. 29, 1987, 101 Stat. 972, provided 
that:
``SEC. 301. REQUIREMENT FOR CLINICAL TRIALS.
    ``(a) In General.--The Director of the National Institute on Aging 
shall provide for the conduct of clinical trials on the efficacy of the 
use of such promising therapeutic agents as have been or may be 
discovered and recommended for further scientific analysis by the 
National Institute on Aging and the Food and Drug Administration to 
treat individuals with Alzheimer's disease, to retard the progression of 
symptoms of Alzheimer's disease, or to improve the functioning of 
individuals with such disease.
    ``(b) Rule of Construction.--Nothing in this title shall be 
construed to affect adversely any research being conducted as of the 
date of the enactment of this Act [Nov. 29, 1987].
``SEC. 302. AUTHORIZATION OF APPROPRIATIONS.
    ``For the purpose of carrying out section 301, there is authorized 
to be appropriated $2,000,000 for fiscal year 1988.''


                      Alzheimer's Disease Registry

    Section 12 of Pub. L. 99-158, which was formerly set out as a note 
under this section, was renumbered section 445G of the Public Health 
Service Act by Pub. L. 103-43, title VIII, Sec. 801(a), 107 Stat. 163, 
and is classified to section 285e-9 of this title.

                  Section Referred to in Other Sections

    This section is referred to in sections 285e-4, 285e-5, 11212, 
11221, 11251, 11292, 11293 of this title.
